A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.

C C Schimanski, S Kasper, S Hegewisch-Becker, J Schroeder, F Overkamp, F Kullmann, W O Bechstein, M Vöhringer, R Oellinger, F Lordick, V Heinemann, M Geissler, A Schulz-Abelius, B Linz, H Bernhard, M R Schoen, R Greil, V Smith-Machnow, I Schmidtmann, M H Moehler, 2019.

Journal of Clinical Oncology 37, no. 15_suppl (May 20 2019) 3537-3537. DOI: 10.1200/JCO.2019.37.15_suppl.3537

Abstract